Capha Pharmaceuticals Inc. Stock

Stocks

31/07/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
29/05/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25/04/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/04/25	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
18/10/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
30/07/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
30/05/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
27/04/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
26/04/24	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
29/11/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
29/08/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
30/05/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
27/04/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Manager	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	13/01/2004

Director	Title	Age	Since
Janice Brown BRD	Director/Board Member	-	13/01/2004
Herbert Leary BRD	Director/Board Member	-	25/10/2010
James Brown CHM	Chairman	-	31/10/2002

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
11/11/21	Janice Brown	Free	Director	888,036	1.3783%
11/11/21	James Brown	Free	Chief Executive Officer	888,036	1.3783%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CAPHA PHARMACEUTICALS INC.	-.--%	-99.00%	-	-	64
ELI LILLY AND COMPANY	+0.18%	-3.69%	+45.63%	+129.38%	1,216B
JOHNSON & JOHNSON	+0.17%	-0.34%	+45.62%	+79.48%	656B
ABBVIE INC.	+0.28%	-2.13%	+31.75%	+104.39%	509B
ROCHE HOLDING AG	-1.44%	-4.61%	+45.10%	+62.26%	384B
MERCK & CO., INC.	-0.12%	-1.82%	+71.14%	+40.70%	362B
NOVARTIS AG	-1.13%	-0.97%	+29.98%	+57.26%	311B
ASTRAZENECA PLC	-1.13%	-0.92%	+7.78%	+34.60%	293B
AMGEN INC.	+0.32%	-1.26%	+45.80%	+68.65%	249B
GILEAD SCIENCES, INC.	+0.16%	-1.76%	+35.88%	+106.66%	208B
Average	-0.24%	+0.60%	+39.85%	+75.93%	465.31B
Weighted average by Cap.	-0.16%	+0.03%	+41.81%	+87.97%